0001203311-20-000051.txt : 20200519 0001203311-20-000051.hdr.sgml : 20200519 20200519191115 ACCESSION NUMBER: 0001203311-20-000051 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200515 FILED AS OF DATE: 20200519 DATE AS OF CHANGE: 20200519 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Simonian Nancy A CENTRAL INDEX KEY: 0001359574 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 20895248 MAIL ADDRESS: STREET 1: C/O SYROS PHARMACEUTICALS, INC. STREET 2: 620 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-05-15 0 0001060736 SEATTLE GENETICS INC /WA SGEN 0001359574 Simonian Nancy A 21823 30TH DRIVE SE BOTHELL WA 98021 1 0 0 0 Common Stock 2020-05-15 4 A 0 1335 0.0 A 26098 D Non-Qualified Stock Option (right to buy) 160.33 2020-05-15 4 A 0 3171 0.0 A 2021-05-15 2030-05-15 Common Stock 3171 3171 D These restricted stock units will be settled in common stock upon vesting. These restricted stock units shall vest in full on May 15, 2021. Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. By: /s/ Jean Liu For: Nancy A. Simonian 2020-05-19